AI summary by TwinMind
How Your Brain’s Reward Circuits Drive Your Choices | Dr. Robert Malenka
Andrew Huberman
2h 50m 3s
Introduction and Background
- Andrew Huberman introduces Dr. Robert Malenka, professor of Psychiatry and Behavioral Sciences at Stanford
- Malenka is MD/PhD, famous for discovering key neuroplasticity components
- Research merged neuroplasticity field with dopamine/reward systems
- Laboratory has shown how seeking pleasure changes reward circuitry and dopamine release
- Work informs understanding of healthy pleasures (food, social connection) vs unhealthy ones
Dopamine System Overview
- Dopamine = major neuromodulator, best known for brain's reward circuitry
- Reward circuitry evolved for survival - tells us what's reinforcing/important in environment
- Not accident that high-fat/sugary foods, sex, warmth when cold are highly rewarding
- System also activated by dangerous/aversive stimuli (important for survival awareness)
- Dopamine neurons located in ventral tegmental area (VTA) - "floor of midbrain"
- Project to nucleus accumbens (part of ventral striatum) via axons
- Release of dopamine in nucleus accumbens creates experience of something important/salient happening
- Close ties to memory systems (evolutionary advantage to remember important events)
- System highly plastic - constantly changing strength of connections
Context and Complexity of Reward
- Context makes enormous difference in dopamine response
- Example: Thanksgiving morning smells vs evening (same stimuli, opposite responses)
- Relationship example: love of life can become source of frustration in minutes
- Brain rapidly changes response to same stimuli based on context
- Dopamine neurons receive inputs from all over brain (visual, somatosensory areas)
- Nucleus accumbens receives inputs from:
- Hippocampus (memory)
- Amygdala (emotions)
- Prefrontal cortex (decision making, planning)
Prefrontal Cortex Role
- Not just "higher executive function" - directly connected to reward circuits
- Sets rules and context for reward responses
- Determines appropriate behaviors for different situations
- Can shift reward valuation based on current goals/context
Addiction Mechanisms
- Addictive liability correlates with:
- Amount of dopamine released in accumbens
- Kinetics (speed) of dopamine release
- Route of administration affects kinetics (smoking vs snorting vs injecting)
- Crack cocaine epidemic dangerous due to rapid brain entry → rapid dopamine surge
- Single drug exposure can cause lasting synaptic changes (days to weeks)
- Changes similar to those evolved for adaptive learning/memory
- Not everyone who uses becomes addicted - complex interaction of genetics, environment, other reward sources
Social Behavior and Reward Circuitry
- Lab transitioned from studying addiction/depression to social behaviors
- Social interactions highly reinforcing for most people evolutionarily
- Advantages: finding mates, protection from predators, child-rearing assistance
- Oxytocin research with postdoc Gül Dölen
- Prairie voles as model - monogamous pair bonding species
- Oxytocin action in nucleus accumbens important for promoting sociability
- Surprising finding: oxytocin enhances serotonin release in nucleus accumbens
Serotonin's Role in Social Behavior
- Serotonin neurons in dorsal raphe nucleus project throughout brain
- Serotonin and dopamine systems interact - don't work in isolation
- Oxytocin released in both nucleus accumbens and VTA
- Can modulate dopamine neuron activity in VTA
- Complex interplay: oxytocin → serotonin release in accumbens
- Different brain regions show different oxytocin-serotonin relationships
Nucleus Accumbens Circuit Details
- Contains two main cell types - "accelerator" and "brake" neurons
- Dopamine drives activity of one type (promoting behaviors)
- Inhibits activity of other type (acts as brake on behaviors)
- Manages probabilities of different behavioral choices
- Critical for social behavior selection and inhibition
Empathy Research
- Motivated by global need for increased empathy and compassion
- Behavioral models of empathy in mice with Monique Smith (now at UCSD)
- Social transfer of pain: mouse in pain causes bystander mouse to experience pain
- Social transfer of analgesia: mouse with pain relief helps nearby mouse in pain
- Communication likely through olfactory cues/pheromones
- Generosity assays: will mouse work to give reward to another mouse
- Compassion assays: will mouse work to prevent another mouse from getting shocked
- Involves anterior cingulate cortex → nucleus accumbens projections
- Same brain areas active in human empathy studies
Autism and Social Reward
- Autism spectrum disorder highly heterogeneous
- Need to respect both those who don't want to be labeled as having "disorder" and those needing help
- Some individuals may have reduced reinforcement from social interactions
- Could be genetic wiring differences or early experience effects
- Mouse models show social interaction deficits
- Deficits can be rescued by serotonin system manipulations
- Current FDA approved drugs only for agitation, not social deficits
- Traditional serotonin drugs (SSRIs) haven't shown efficacy in clinical trials
MDMA Research and Mechanisms
- MDMA = amphetamine derivative affecting both dopamine and serotonin systems
- Not 50/50 split - approximately 70% serotonin, 30% dopamine effects
- Prevents reuptake AND causes reverse transport ("vomiting out" neurotransmitters)
- Different subjective experience from cocaine/methamphetamine due to serotonin component
- Hypothesis: addictive liability from dopamine effects, pro-social effects from serotonin
- Testing MDMA in mouse empathy models - hypothesis being supported
- Serotonin release in accumbens modulates dopamine release
MDMA Clinical Applications
- Has some addictive liability due to amphetamine properties
- Powerful pro-social effects, called "empathogen" by some
- FDA may approve for PTSD treatment as adjunct to psychotherapy
- Maps organization deserves credit for 30-year research effort
- Small trials in high-functioning individuals with social anxiety
- MindMed studying different MDMA enantiomers:
- S-enantiomer: higher dopamine interaction
- R-enantiomer: higher serotonin interaction
- Malenka's company (MapLight Therapeutics) developing serotonin 1B receptor targeted drug for autism
Social Media and Digital Addiction
- Capitalizes on hardwired social reward circuitry
- Not same intensity as in-person interaction for most people
- Malenka admits compulsive phone/email checking behavior
- Activates reward circuitry but not to degree of drugs of abuse
- Concern about societal implications, especially for children
- Similar to how gambling industry uses neuroscience principles
Psychedelics Landscape and Cautions
- Excited but cautious about current psychedelics research renaissance
- Divides into categories: classic hallucinogens (LSD, psilocybin), entactogens (MDMA), others
- Should be subject to rigorous, sophisticated, ethical research
- Not miracle cures - may have therapeutic potential for some individuals
- Concerned about bad experiences leading to research backlash
- Personal experience with "bad trips" in 1970s provided insight into severe depression
- Clinical trials have strict inclusion/exclusion criteria
- Worry that uncontrolled use could harm legitimate research efforts
Career Development Insights
- Started as shy, insecure student doubting own ideas
- Confidence built gradually through postdoc training with Roger Nicoll
- Developed thicker skin through scientific arguments and debates
- Always felt like working for himself, not just for mentors
- Emphasized importance of treating trainees as colleagues/equals
- 40-year career running independent laboratory
